| ALCON AG NAM. SF -,04 |
| Schweiz |
| Gesundheit |
| CH0432492467 / A2PDXE |
| 2U3 (Frankfurt) / ALC (NYSE) |
| FRA:2U3, ETR:2U3, 2U3:GR, NYSE:ALC |
| SMI |
| https://www.alcon.com/ |
|
Alcon Inc. is a leading global company specializin..
>Volltext.. |
| 31694.52 Mio. EUR |
| 34993.21 Mio. EUR |
| 9479.11 Mio. EUR |
| 2593.15 Mio. EUR |
| 1022.29 Mio. EUR |
| 2.07 EUR |
| 4568.61 Mio. EUR |
| 1222.69 Mio. EUR |
| 1929.7 Mio. EUR |
| 0.58 |
| 4.68% |
| -1.24% |
| - |
| 0.47% |
| 0.47% |
| 10.05.23 - 0.22703099€ 03.05.22 - 0.21622€ >weitere anzeigen... |
| - |
| ALCON |
| 12.11.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|